Acadian Asset Management LLC Has $165.44 Million Stake in The Procter & Gamble Company (NYSE:PG)

Acadian Asset Management LLC lessened its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 25.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,019,793 shares of the company’s stock after selling 339,573 shares during the period. Acadian Asset Management LLC’s holdings in Procter & Gamble were worth $165,436,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of PG. Advantage Trust Co bought a new stake in Procter & Gamble in the 4th quarter valued at $28,000. Naples Money Management LLC acquired a new position in shares of Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at approximately $31,000. Ruedi Wealth Management Inc. lifted its stake in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. Finally, Criterion Capital Advisors LLC acquired a new position in Procter & Gamble during the 4th quarter worth approximately $33,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares in the company, valued at approximately $3,179,061.90. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, COO Shailesh Jejurikar sold 31,859 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the sale, the chief operating officer now owns 9,739 shares in the company, valued at approximately $1,605,961.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 154,544 shares of company stock worth $25,413,051. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE PG traded up $0.52 during trading hours on Friday, reaching $167.96. 6,597,090 shares of the stock were exchanged, compared to its average volume of 6,185,252. The stock’s fifty day simple moving average is $166.30 and its 200 day simple moving average is $160.91. The firm has a market capitalization of $396.41 billion, a price-to-earnings ratio of 27.44, a P/E/G ratio of 3.15 and a beta of 0.41. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $170.92. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. During the same quarter in the previous year, the business posted $1.37 earnings per share. Procter & Gamble’s quarterly revenue was up .6% on a year-over-year basis. Sell-side analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Argus boosted their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Jefferies Financial Group boosted their price target on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research report on Monday, April 22nd. Deutsche Bank Aktiengesellschaft raised their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday. BNP Paribas initiated coverage on Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Finally, StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Tuesday, July 16th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $172.75.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.